Docket #: S02-234
Deriving Pure Compositions of Mammalian Megakaryocyte Progenitor Cells
Please see issued patent and publication, below, for details.
Publications
Patents
- Published Application: 20050176142
Similar Technologies
-
Systemic targeting of inflammatory sites and enhanced immunomodulatory function by introducing the chimeric antigen receptor (CAR) into mesenchymal stem cells for inflammatory and autoimmune diseases S17-417Systemic targeting of inflammatory sites and enhanced immunomodulatory function by introducing the chimeric antigen receptor (CAR) into mesenchymal stem cells for inflammatory and autoimmune diseases
-
Lymphodepletion by Selective Apoptosis Induction in T Cells for Safe and Effective Immune Tolerance in Immunotherapy, Transplantation, and Autoimmunity S22-458Lymphodepletion by Selective Apoptosis Induction in T Cells for Safe and Effective Immune Tolerance in Immunotherapy, Transplantation, and Autoimmunity
-
Rapid iPS Cells from Adult Human Adipose Stem Cells S08-438Rapid iPS Cells from Adult Human Adipose Stem Cells